Initial email exchange/conversation between (b)(4), region manager, (b)(4) representing manufacturer and mr.(b)(4), administrator and ms.(b)(4), director of resident care representing complainant took place early morning on (b)(6) 2018.On monday (b)(4), (b)(4) and (b)(4) (manufacturer representatives) visited the health care facility to investigate and evaluate the medical device involved in the incident and interview the facility staff in regards the incident.The bed, the assist rail, and the mattress found to be complaint with (b)(4) and fda guidelines.The mattress in use was from other manufacturer.The mattress identification label was not present.At the time of the incident the bed height was 27" measured from the top of the mattress.The lowest position on this bed model is about 14".The back section of the bed was articulated between 15° and 30°.The rail assist device used is very narrow device mounted in the middle section of the bed for the purpose to facilitate easy resident ingress and egress.The incident was due to no fault of the bed.The bed in question was manufactured and conforms to iec60601-2-38, medical electrical equipment part 2: particular requirements for the safety of electrically operated hospital beds, standard.The product is certified by (b)(4), (b)(4) approved cb testing laboratories.The bed and mattress was entrapment tested by the facility on august, 3, 2017.(b)(4) will take no further action and considers this the final report submission.
|